1. Home
  2. EDBL vs ACON Comparison

EDBL vs ACON Comparison

Compare EDBL & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edible Garden AG Incorporated

EDBL

Edible Garden AG Incorporated

HOLD

Current Price

$1.21

Market Cap

4.0M

ML Signal

HOLD

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$6.20

Market Cap

3.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDBL
ACON
Founded
2020
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Staples
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
3.6M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
EDBL
ACON
Price
$1.21
$6.20
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$23.00
AVG Volume (30 Days)
66.7K
12.5K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,553,000.00
$67,483.00
Revenue This Year
$29.56
$145.39
Revenue Next Year
$20.00
$145.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.91
52 Week Low
$1.05
$5.55
52 Week High
$13.50
$3,499.49

Technical Indicators

Market Signals
Indicator
EDBL
ACON
Relative Strength Index (RSI) 43.23 37.06
Support Level $1.05 $5.55
Resistance Level $1.25 $6.25
Average True Range (ATR) 0.12 0.34
MACD 0.01 0.00
Stochastic Oscillator 60.00 39.95

Price Performance

Historical Comparison
EDBL
ACON

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Share on Social Networks: